Daily reported cases in the last week increased to 68,900 per day on average compared
to 66,700 the week before, an increase of 3%
Daily deaths in the last week decreased slightly to 670 per day on average compared to
700 the week before. COVID-19 remains the number 2 cause of death in the
US this week.
The daily death rate is greater than 4 per million in Michigan.
We estimated that 30% of people in the US have been infected as of April 19.
Our estimate of the percent infected to date has increased considerably from last week
due to introducing corrections for waning antibodies in our analysis of seroprevalence
Effective R, computed using cases, hospitalizations, and deaths, is greater than 1 in 34
The infection-detection rate in the US is close to 40%. After correcting for
waning antibodies in seroprevalence surveys, our estimate of the infection-detection
rate is down from our previous estimates.
Based on GISAID and CDC sequence data combined with our variant spread model,
we estimate current prevalence of key variants. B.1.1.7 is becoming the
dominant variant in most of the US. While B.1.351 and P1 have been sequenced in
many states, as in Europe, these variants are not increasing in prevalence in the
presence of B.1.1.7.
Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021
Outpatient Visits for COVID-19 and Associated Antibiotic Prescriptions Among Medicare Beneficiaries Aged 65 Years or Older, by Setting, US, April 2020 to April 2021. The volume of COVID-19 visits differed by setting: emergency department, 525 608 (45.8% of all visits); office, 295 983 (25.3%); telehealth, 260 261 (22.3%); and urgent care, 77 268 (6.6%).
Source: Journal of American Medical Association Network